Showing results (1811-1820 of 2,261) with videos related to

Sort By:
Pageof 227
Hepatology (Baltimore, Md.)|January 31, 2004
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitisKittichai Promrat, Glen Lutchman, Gabriel I Uwaifo, et al.
Gynecologic Oncology|February 15, 2012
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can)Hanno Ulmer, Tone Bjørge, Hans Concin, et al.
Cardiovascular Research|June 3, 2011
Syndecan-4 signalling inhibits apoptosis and controls NFAT activity during myocardial damage and remodellingFrank Echtermeyer, Thomas Harendza, Svenja Hubrich, et al.
Annals of Internal Medicine|August 6, 2000
Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromesE Arioglu, J Duncan-Morin, N Sebring, et al.
Journal of Hepatology|September 24, 2022
Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injuryNaga Chalasani, Yi-Ju Li, Andrew Dellinger, et al.
Plos Pathogens|April 18, 2006
A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous diseaseDavid E Greenberg, Li Ding, Adrian M Zelazny, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2020
Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosisDaniela S Allende, Samer Gawrieh, Oscar W Cummings, et al.
Nature Metabolism|February 20, 2026
Single-cell spatial proteomics maps human liver zonation patterns and their vulnerability to disruption in tissue architectureCaroline A M Weiss, Lauryn A Brown, Lucas Miranda, et al.
Pageof 227